RU2001101892A - Производное тестостерона - Google Patents
Производное тестостеронаInfo
- Publication number
- RU2001101892A RU2001101892A RU2001101892/04A RU2001101892A RU2001101892A RU 2001101892 A RU2001101892 A RU 2001101892A RU 2001101892/04 A RU2001101892/04 A RU 2001101892/04A RU 2001101892 A RU2001101892 A RU 2001101892A RU 2001101892 A RU2001101892 A RU 2001101892A
- Authority
- RU
- Russia
- Prior art keywords
- undecanoate
- ment
- pharmaceutical composition
- composition according
- testosterone derivative
- Prior art date
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical class O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title 1
- YSGQGNQWBLYHPE-CFUSNLFHSA-N (7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 claims 5
- ZDPHROOEEOARMN-UHFFFAOYSA-M undecanoate Chemical compound CCCCCCCCCCC([O-])=O ZDPHROOEEOARMN-UHFFFAOYSA-M 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- -1 1-oxoundecyl Chemical group 0.000 claims 1
- 206010002261 Androgen deficiency Diseases 0.000 claims 1
- 239000003098 androgen Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 239000000583 progesterone congener Substances 0.000 claims 1
Claims (6)
1. Соединение (7α,17β)-7-метил-17-[(1-оксоундецил)окси] эстр-4-ен-3-он (ундеканоат МЕНТ).
2. Ундеканоат МЕНТ в качестве лекарственного средства.
3. Применение ундеканоата МЕНТ для получения лекарственного средства для лечения андрогенной недостаточности.
4. Фармацевтическая композиция, содержащая ундеканоат МЕНТ и фармацевтически приемлемый носитель.
5. Фармацевтическая композиция по п. 4, отличающаяся тем, что носитель является жидкостью, в которой растворяется ундеканоат МЕНТ.
6. Набор для мужской контрацепции, включающий средства для введения прогестагена и средства для введения андрогена, отличающийся тем, что последний означает фармацевтическую композицию по п. 5.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98202052.1 | 1998-06-19 | ||
| EP98202052 | 1998-06-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2001101892A true RU2001101892A (ru) | 2003-01-27 |
| RU2216546C2 RU2216546C2 (ru) | 2003-11-20 |
Family
ID=8233831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2001101892/04A RU2216546C2 (ru) | 1998-06-19 | 1999-06-14 | СОЕДИНЕНИЕ (7α,17β)-7-МЕТИЛ-17-[(1-ОКСОУНДЕЦИЛ)ОКСИ]ЭСТР-4-ЕН-3-ОН, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, НАБОР ДЛЯ МУЖСКОЙ КОНТРАЦЕПЦИИ |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US6437158B1 (ru) |
| EP (1) | EP1087986B1 (ru) |
| JP (1) | JP2002518514A (ru) |
| KR (1) | KR100596649B1 (ru) |
| CN (1) | CN1172949C (ru) |
| AT (1) | ATE215961T1 (ru) |
| AU (1) | AU756739B2 (ru) |
| BR (1) | BR9911344A (ru) |
| CA (1) | CA2333985C (ru) |
| CZ (1) | CZ293319B6 (ru) |
| DE (1) | DE69901250T2 (ru) |
| DK (1) | DK1087986T3 (ru) |
| ES (1) | ES2175989T3 (ru) |
| HK (1) | HK1034263A1 (ru) |
| HU (1) | HUP0102274A3 (ru) |
| ID (1) | ID27260A (ru) |
| IL (1) | IL139689A (ru) |
| NO (1) | NO316518B1 (ru) |
| NZ (1) | NZ508299A (ru) |
| PL (1) | PL191285B1 (ru) |
| PT (1) | PT1087986E (ru) |
| RU (1) | RU2216546C2 (ru) |
| SK (1) | SK282796B6 (ru) |
| TR (1) | TR200003743T2 (ru) |
| WO (1) | WO1999067271A1 (ru) |
| ZA (1) | ZA200006813B (ru) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1212345B1 (en) * | 1999-04-06 | 2003-08-06 | Akzo Nobel N.V. | Orally active 7-alpha-alkyl androgens |
| BR0112791A (pt) * | 2000-07-28 | 2003-06-24 | Akzo Nobel Nv | Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica |
| JP3774888B2 (ja) * | 2001-11-28 | 2006-05-17 | 日本化薬株式会社 | ステロイド類化合物のｌｃ−ｍｓによる高感度検出法 |
| TW200404552A (en) * | 2002-05-30 | 2004-04-01 | Akzo Nobel Nv | Self administered contraception |
| TW200403065A (en) | 2002-05-30 | 2004-03-01 | Akzo Nobel Nv | New etonogestrel esters |
| TW200400041A (en) * | 2002-05-30 | 2004-01-01 | Akzo Nobel Nv | Use of new etonogestrel esters |
| GB0304927D0 (en) | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
| JO2505B1 (en) | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | Pharmacy methods and formulations for obtaining acceptable serum testosterone levels |
| JO2492B1 (en) | 2003-04-28 | 2009-10-05 | شيرينج ايه جي | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
| PE20050677A1 (es) | 2003-12-22 | 2005-10-04 | Akzo Nobel Nv | Esteroides con perfil androgenico y progestagenico mixto |
| UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
| EP1879382B1 (en) | 2006-07-10 | 2017-09-06 | Samsung Electronics Co., Ltd. | Multi-screen display apparatus and method for digital broadcast receiver |
| WO2008101030A1 (en) * | 2007-02-13 | 2008-08-21 | The Regents Of The University Of California | Methods for amplifying steroid hormone effects |
| US20090017107A1 (en) * | 2007-07-13 | 2009-01-15 | Oral Delivery Technology Ltd. | Novel composition to increase libido |
| US20090018107A1 (en) * | 2007-07-13 | 2009-01-15 | Oral Delivery Technology Ltd. | Novel composition to increase muscle strength |
| US20100303937A1 (en) * | 2009-06-01 | 2010-12-02 | Michael Farber | Novel composition to increase testosterone levels |
| CN102558267A (zh) * | 2012-01-13 | 2012-07-11 | 宜城市共同药业有限公司 | 庚酸睾酮的制备方法 |
| CA2868500C (en) * | 2012-04-06 | 2020-04-21 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
| EP3659647B1 (en) | 2013-02-11 | 2024-01-24 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5342834A (en) | 1989-04-07 | 1994-08-30 | The Population Council, Inc. | Method for androgen supplementation |
-
1999
- 1999-06-14 TR TR2000/03743T patent/TR200003743T2/xx unknown
- 1999-06-14 IL IL13968999A patent/IL139689A/en not_active IP Right Cessation
- 1999-06-14 CA CA002333985A patent/CA2333985C/en not_active Expired - Fee Related
- 1999-06-14 AU AU46101/99A patent/AU756739B2/en not_active Ceased
- 1999-06-14 HU HU0102274A patent/HUP0102274A3/hu unknown
- 1999-06-14 AT AT99929208T patent/ATE215961T1/de not_active IP Right Cessation
- 1999-06-14 CN CNB998075175A patent/CN1172949C/zh not_active Expired - Fee Related
- 1999-06-14 WO PCT/EP1999/004102 patent/WO1999067271A1/en active IP Right Grant
- 1999-06-14 US US09/719,927 patent/US6437158B1/en not_active Expired - Fee Related
- 1999-06-14 PL PL344987A patent/PL191285B1/pl not_active IP Right Cessation
- 1999-06-14 ES ES99929208T patent/ES2175989T3/es not_active Expired - Lifetime
- 1999-06-14 ID IDW20002632A patent/ID27260A/id unknown
- 1999-06-14 CZ CZ20004779A patent/CZ293319B6/cs not_active IP Right Cessation
- 1999-06-14 PT PT99929208T patent/PT1087986E/pt unknown
- 1999-06-14 BR BR9911344-9A patent/BR9911344A/pt not_active Application Discontinuation
- 1999-06-14 DE DE69901250T patent/DE69901250T2/de not_active Expired - Fee Related
- 1999-06-14 EP EP99929208A patent/EP1087986B1/en not_active Expired - Lifetime
- 1999-06-14 SK SK1940-2000A patent/SK282796B6/sk not_active IP Right Cessation
- 1999-06-14 RU RU2001101892/04A patent/RU2216546C2/ru not_active IP Right Cessation
- 1999-06-14 JP JP2000555922A patent/JP2002518514A/ja active Pending
- 1999-06-14 DK DK99929208T patent/DK1087986T3/da active
- 1999-06-14 NZ NZ508299A patent/NZ508299A/xx unknown
- 1999-06-14 KR KR1020007014182A patent/KR100596649B1/ko not_active IP Right Cessation
-
2000
- 2000-11-21 ZA ZA200006813A patent/ZA200006813B/en unknown
- 2000-12-18 NO NO20006455A patent/NO316518B1/no unknown
-
2001
- 2001-07-10 HK HK01104759A patent/HK1034263A1/xx not_active IP Right Cessation
-
2002
- 2002-06-21 US US10/177,989 patent/US20040033999A1/en not_active Abandoned
-
2004
- 2004-10-13 US US10/964,076 patent/US6989378B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2001101892A (ru) | Производное тестостерона | |
| DK0402950T3 (da) | Behandling af postmenopausale ulemper | |
| EG19642A (en) | A process for the preparation of oral composition for the treatment of inflammatory bowel diseases | |
| RU96115196A (ru) | Состав для контрацепции | |
| RU98115774A (ru) | Новые производные 19-нор-прегнена | |
| ATE216241T1 (de) | Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung | |
| HK1050839A1 (en) | Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state | |
| RU2002103883A (ru) | Перорально активные андрогены | |
| RU2001129362A (ru) | Композиция, включающая ундеканоат тестостерона и касторовое масло | |
| HUP0103494A2 (en) | Process for intermittent administration use of growth hormone secretagogues for the manufacture of pharmaceutical compositions for intermittent administration and kit comprising thereof | |
| CA2431645A1 (en) | Methods of treating hormonal deficiencies in women undergoing estrogen replacement therapy | |
| PT92168B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de nucleos de estrogenios para provocar a inibicao da actividade de esteroides sexuais | |
| BR9912466A (pt) | Utilização de sulfamatos de estrogênio biogênicos na terapia de reposição hormonal | |
| ATE241363T1 (de) | Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen | |
| CA2389025A1 (fr) | Composition hormonale a base d'un progestatif et d'un oestrogene et son utilisation | |
| MY128482A (en) | New hormonal composition and its use | |
| RU94046463A (ru) | Антиандрогенное соединение, предшественник лекарственного средства, фармацевтические композиции, способ лечения или предотвращения заболеваний | |
| RU2000115313A (ru) | Схемы приема гестаген-анти-гестагена | |
| AP1707A (en) | Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same. | |
| JP2005532336A5 (ru) | ||
| CA2382106A1 (en) | Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds | |
| UA66925C2 (ru) | Полиморфные формы кристаллического цитрата азабицикло[2.2.2]-октан-3-амина, способ их получения, фармацевтичкая композиция и способ лечения рвоты | |
| RU1789216C (ru) | Состав, обладающий контрацептивным действием | |
| RU2002117297A (ru) | 3-метиленстероидные производные | |
| RU2006126632A (ru) | Стероиды, имеющие смешанный андрогенный и прогрестагенный профиль |